First Light Asset Management, LLC Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$315.8B
Holdings
52
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (52 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NEONEOGENOMICS INC | 2,407,930 | $26.8B | 8.49% | |
| 2 | ATRCATRICURE INC | 1,033,736 | $23.1B | 7.32% | |
| 3 | —IMMUNOMEDICS INC | 1,311,514 | $18.3B | 5.81% | |
| 4 | ARRYEURARRAY BIOPHARMA INC | 1,469,461 | $18.1B | 5.72% | |
| 5 | HBIOHARVARD BIOSCIENCE INC | 4,116,282 | $15.4B | 4.89% | |
| 6 | OMCLOMNICELL INC | 298,219 | $15.2B | 4.82% | |
| 7 | MODNEURMODEL N INC | 851,708 | $12.7B | 4.03% | |
| 8 | NKTREURNEKTAR THERAPEUTICS | 503,193 | $12.1B | 3.82% | |
| 9 | —ENTELLUS MEDICAL INC | 632,737 | $11.7B | 3.70% | |
| 10 | —SHIRE PLC | 74,470 | $11.4B | 3.61% | |
| 11 | —TELIGENT INC | 1,483,343 | $10.0B | 3.15% | |
| 12 | —OXFORD IMMUNOTEC GLOBAL PLC | 562,377 | $9.4B | 2.99% | |
| 13 | LGNDLIGAND PHARMACEUTICALS INC | 63,346 | $8.6B | 2.73% | |
| 14 | —MEDICINES COMPANY | 220,300 | $8.2B | 2.58% | |
| 15 | HALOHALOZYME THERAPEUTICS INC | 445,846 | $7.7B | 2.45% | |
| 16 | VCYTVERACYTE INC | 841,959 | $7.4B | 2.34% | |
| 17 | HRTXHERON THERAPEUTICS INC | 393,505 | $6.4B | 2.01% | |
| 18 | DVAXDYNAVAX TECHNOLOGIES CORP | 273,930 | $5.9B | 1.86% | |
| 19 | —K2M GROUP HOLDINGS INC | 275,173 | $5.8B | 1.85% | |
| 20 | NVROEURNEVRO CORP | 59,905 | $5.4B | 1.72% | |
| 21 | QDELUSDQUIDEL CORP | 122,509 | $5.4B | 1.70% | |
| 22 | GMEDGLOBUS MEDICAL INC | 179,016 | $5.3B | 1.68% | |
| 23 | —INTERSECT ENT INC | 170,197 | $5.3B | 1.68% | |
| 24 | —NXSTAGE MEDICAL INC | 183,592 | $5.1B | 1.60% | |
| 25 | —BLUEBIRD BIO INC | 36,085 | $5.0B | 1.57% | |
| 26 | TECHBIO TECHNE CORP | 38,654 | $4.7B | 1.48% | |
| 27 | HSTMHEALTHSTREAM INC | 199,243 | $4.7B | 1.47% | |
| 28 | LHCGUSDLHC GROUP INC | 64,672 | $4.6B | 1.45% | |
| 29 | VRTXVERTEX PHARMACEUTICALS INC | 23,421 | $3.6B | 1.13% | |
| 30 | BMRNBIOMARIN PHARMACEUTICAL INC | 31,902 | $3.0B | 0.94% | |
| 31 | MGNXMACROGENICS INC | 151,670 | $2.8B | 0.89% | |
| 32 | —STREAMLINE HEALTH SOLUTIONS | 1,760,706 | $2.6B | 0.82% | |
| 33 | IBBISHARES NASDAQ BIOTECHNOLOGY ETF | 7,097 | $2.4B | 0.75% | |
| 34 | ENZBENZO BIOCHEM INC | 225,616 | $2.4B | 0.75% | |
| 35 | CDXSCODEXIS INC | 344,990 | $2.3B | 0.73% | |
| 36 | IRIXIRIDEX CORP | 238,795 | $2.2B | 0.71% | |
| 37 | ISIIONIS PHARMACEUTICALS INC | 42,511 | $2.2B | 0.68% | |
| 38 | CELGCELGENE CORP | 13,856 | $2.0B | 0.64% | |
| 39 | LMATLEMAITRE VASCULAR INC | 46,816 | $1.8B | 0.55% | |
| 40 | —POWERSHARES S&P SMALLCAP HEALTH CARE ETF | 17,285 | $1.6B | 0.51% | |
| 41 | ALKSALKERMES PLC | 30,087 | $1.5B | 0.48% | |
| 42 | XLVHEALTH CARE SELECT SECTOR SPDR ETF | 18,241 | $1.5B | 0.47% | |
| 43 | IHIISHARES US MEDICAL DEVICES ETF | 7,580 | $1.3B | 0.40% | |
| 44 | XBISPDR S&P BIOTECH ETF | 9,499 | $822.0M | 0.26% | |
| 45 | ABBVABBVIE | 4,159 | $370.0M | 0.12% | |
| 46 | SNYSANOFI-SYNTHELABO | 6,720 | $335.0M | 0.11% | |
| 47 | NVSNNOVARTIS A G | 3,572 | $307.0M | 0.10% | |
| 48 | PFEPFIZER INC | 8,558 | $306.0M | 0.10% | |
| 49 | JNJJOHNSON AND JOHNSON | 2,183 | $284.0M | 0.09% | |
| 50 | MRKMERCK & CO INC | 4,294 | $275.0M | 0.09% | |
| 51 | DYNTQDYNATRONICS CORP | 102,024 | $231.0M | 0.07% | |
| 52 | AMGNAMGEN INC | 1,105 | $207.0M | 0.07% |